Skip to main content

Table 1 Clinical characteristics of the patients

From: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery

  all BMI < 37.5 BMI ≥ 37.5 P value
n 90 37 53 /
Male [n(%)] 43 (47.8) 15 (40.5) 28 (52.8) 0.251
Age (years) 30.58 ± 9.48 31.78 ± 9.78 29.74 ± 9.26 0.316
Waist (cm) 119.98 ± 15.23 106.95 ± 11.23 128.56 ± 10.79 < 0.001
ALT (U/L) 58.94 ± 50.80 57.56 ± 55.43 59.90 ± 47.83 0.831
AST (U/L) 32.70 ± 23.72 29.82 ± 20.66 34.71 ± 25.63 0.339
γGT (U/L) 48.99 ± 39.28 40.35 ± 22.18 54.40 ± 46.34 0.113
Glucose (mmol/L) 5.97 ± 1.94 6.18 ± 2.21 5.82 ± 1.73 0.405
HbA1c (%) 6.78 ± 1.87 6.76 ± 2.09 6.80 ± 1.72 0.919
TG (mmol/L) 1.91 ± 1.08 2.03 ± 0.98 1.83 ± 1.15 0.400
TC (mmol/L) 4.60 ± 0.80 4.61 ± 0.86 4.59 ± 0.77 0.899
LCN2 (ng/mL) 103.81 ± 45.26 92.68 ± 32.68 111.59 ± 51.16 0.035
CAP (dB/m) 352.40 ± 45.88 340.78 ± 45.02 360.51 ± 45.14 0.044
  1. Results are shown as mean ± SD or number (percentage)
  2. BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; γGT: glutamyltransferase; TG: triglyceride; TC: total cholesterol; CAP: controlled attenuation parameter